Copia Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Copia Wealth Management's LLY Position: Q1 2026 in Review
Copia Wealth Management reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $1.01K and leaving 33 shares worth $30.4K. The position accounts for 0.02% of the portfolio, ranked #240.
Copia Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $36.5K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Copia Wealth Management held 33 shares of Eli Lilly worth $30.4K as of Q1 2026.
- Copia Wealth Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
- Eli Lilly made up 0.02% of Copia Wealth Management's portfolio in Q1 2026, its #240 holding.
- Copia Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Copia Wealth Management's Eli Lilly position peaked at $36.5K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Copia Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.